Literature DB >> 29397943

Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer.

Sachin Wani, Bashar Qumseya, Shahnaz Sultan, Deepak Agrawal, Vinay Chandrasekhara, Ben Harnke, Shivangi Kothari, Martin McCarter, Aasma Shaukat, Amy Wang, Julie Yang, John Dewitt.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29397943     DOI： 10.1016/j.gie.2017.10.011

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  26 in total

1.  Trends in Treatment of T1N0 Esophageal Cancer.

Authors:  Tara R Semenkovich; Jessica L Hudson; Melanie Subramanian; Daniel K Mullady; Bryan F Meyers; Varun Puri; Benjamin D Kozower
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

Review 2.  [Treatment recommendations for early esophageal cancer : Endoscopic and surgical options].

Authors:  T Schlosser; A Hoffmeister; J Feisthammel; S Niebisch; R Thieme; I Gockel
Journal:  Chirurg       Date:  2021-10-07       Impact factor: 0.955

3.  Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel.

Authors:  Sachin Wani; Rena Yadlapati; Siddharth Singh; Tarek Sawas; David A Katzka
Journal:  Gastroenterology       Date:  2021-10-14       Impact factor: 22.682

4.  Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications.

Authors:  Sachin Wani; Rhonda F Souza; Valerie L Durkalski; Jose Serrano; Frank Hamilton; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2022-06-06       Impact factor: 33.883

Review 5.  Best Practices in Surveillance for Barrett's Esophagus.

Authors:  Joseph R Triggs; Gary W Falk
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-10-21

6.  Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia.

Authors:  Durayd Alzoubaidi; Krish Ragunath; Sachin Wani; Ian D Penman; Nigel John Trudgill; Marnix Jansen; Matthew Banks; Pradeep Bhandari; Allan John Morris; Robert Willert; Phil Boger; Howard L Smart; Narayanasamy Ravi; Jason Dunn; Charles Gordon; Jayan Mannath; Inder Mainie; Massi di Pietro; Andrew M Veitch; Sally Thorpe; Cormac Magee; Martin Everson; Sarmed Sami; Paul Bassett; David Graham; Stephen Attwood; Oliver Pech; Prateek Sharma; Laurence B Lovat; Rehan Haidry
Journal:  Frontline Gastroenterol       Date:  2019-08-14

7.  Clinical Outcomes Based on the Timing of Appearance of Visible Lesions in Barrett's Esophagus During Endoscopic Eradication Therapy.

Authors:  Prashanthi N Thota; Tanmayee Benjamin; Madhusudhan R Sanaka; John R Goldblum; John Vargo; Sunguk Jang; Rocio Lopez
Journal:  J Clin Gastroenterol       Date:  2020-02       Impact factor: 3.174

Review 8.  Surveillance of Barrett's esophagus using wide-area transepithelial sampling: systematic review and meta-analysis.

Authors:  Bashar Qumseya; Aymen Bukannan; Robyn Rosasco; Xiuli Liu; Amira Qumseya
Journal:  Endosc Int Open       Date:  2022-04-14

9.  Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus.

Authors:  Chanakyaram A Reddy; Anna Tavakkoli; Vincent L Chen; Sheryl Korsnes; Aarti Oza Bedi; Philip W Carrott; Andrew C Chang; Kiran H Lagisetty; Richard S Kwon; B Joseph Elmunzer; Mark B Orringer; Cyrus Piraka; Anoop Prabhu; Rishindra M Reddy; Erik Wamsteker; Joel H Rubenstein
Journal:  Dig Dis Sci       Date:  2020-06-09       Impact factor: 3.199

10.  Computational modelling suggests that Barrett's oesophagus may be the precursor of all oesophageal adenocarcinomas.

Authors:  Kit Curtius; Joel H Rubenstein; Amitabh Chak; John M Inadomi
Journal:  Gut       Date:  2020-11-24       Impact factor: 31.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.